Quarterly report pursuant to Section 13 or 15(d)

Orion Office REIT, Net Income (Loss) Per Share - Schedule of Antidilutive (Details)

v3.22.1
Orion Office REIT, Net Income (Loss) Per Share - Schedule of Antidilutive (Details) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Time-Based Restricted Stock Units and Performance-Based Restricted Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 765 0
Weighted average stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,120,000 0